Duolingo, Inc. (DUOL)

NasdaqGS Currently up 2.69 (+2.48%) in today's trading session

1 member of Congress has disclosed 3 trades in Duolingo, Inc. (DUOL) via STOCK Act filings. The most recent disclosure was a sale by Lisa McClain on 13 August 2025. Aggregate disclosed activity totals roughly $8K in purchases and $16K in sales (midpoint estimates from bracketed disclosure amounts).

Duolingo, Inc. is currently trading at $111.36, positioned at 5% of its 52-week range ($87.89 – $540.30).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Free asset at sign up • Eligible regions only
Live portfolio tracking
Automatic rebalancing

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Not available in the US.

Past Performance is not an indication of future results.

*Free asset promotion available at sign up in eligible regions only. Terms and conditions apply.

Current Price
$111.36
24h Change
+2.69 (+2.48%)
52 Week Range
$87.89$540.30
View on NASDAQ

Duolingo, Inc. Price History and Technical Analysis

Interactive Chart

Congressional Trading Activity for DUOL

Select to highlight on chart
1 transactions
Compliance: 33%
Lisa McClain13 Aug 202512 Sept 2025SaleStock$1,001 - $15,000N/A

Select transactions to view their annotations on the chart

Stock Overview

Market Data

Market Cap

$5.19B

Volume

1.19M

Beta

0.90

P/E Ratio

12.74

Fundamentals

EPS

$8.74

Div. Yield

Open

$108.50

Day Range

$106.51 — $114.33

Company Information

Sector
Technology
Industry
Software - Application
Exchange
NASDAQ · USD
Country
US
CEO
Luis Alfonso von Ahn Arellano
IPO Date
2021-07-28

Duolingo, Inc. develops a language-learning website and mobile app in the United States and China. The company offers courses in 40 different languages, including Spanish, English, French, Japanese, German, Italian, Chinese, Portuguese, and others. I...

Earnings

Next Report

Q2 2026

5 Aug

EPS Est.

$0.62

Rev. Est.

$295.3M

Days Until

67

Recent Quarters

Q1 20264 May
EPS$0.89
Beat 12.7%
Q4 202526 Feb
EPS$0.94
Beat 19.0%
Q3 20255 Nov
EPS$0.95
Beat 25.2%
Q2 20256 Aug
EPS$0.91
Beat 65.5%
Q1 20251 May
EPS$0.72
Beat 39.8%
Q4 202427 Feb
EPS$0.31
Miss 35.7%
Q3 20246 Nov
EPS$0.49
Beat 40.0%
Q2 20247 Aug
EPS$0.51
Beat 59.4%
Q1 20248 May
EPS$0.57
Beat 111.1%
Q4 202328 Feb
EPS$0.26
Beat 52.9%
Q3 20238 Nov
EPS$0.06
Beat 154.6%
Q2 20238 Aug
EPS$0.08
Beat 142.1%
Q1 20239 May
EPS$-0.06
Beat 75.0%
Q4 202228 Feb
EPS$-0.35
Beat 34.0%
Q3 202210 Nov
EPS$-0.46
Beat 22.0%
Q2 20224 Aug
EPS$-0.38
Beat 24.0%
Q1 202212 May
EPS$-0.31
Beat 47.5%
Q4 20213 Mar
EPS$-0.46
Beat 19.3%
Q3 202110 Nov
EPS$-0.98
Miss 6.5%
Q2 202111 Aug
EPS$-0.01
Q2 202128 Jul
EPS$-0.42
Q3 202031 Dec
EPS$-0.33
Q2 202030 Sept
EPS$-0.10
Q1 202030 Jun
EPS$0.00
Q4 201931 Mar
EPS$-0.07

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about DUOL

Which members of Congress have traded DUOL?
1 member of Congress has disclosed 3 trade in Duolingo, Inc. (DUOL) under the STOCK Act: Lisa McClain.
When was DUOL most recently disclosed by Congress?
The most recent DUOL disclosure was a sale by Lisa McClain on 13 August 2025.
What is the total disclosed congressional trading volume for DUOL?
Members of Congress have disclosed approximately $8K in DUOL purchases and $16K in sales. These figures are midpoint estimates derived from the bracketed amount ranges used in STOCK Act filings.
How can I track new congressional trades in DUOL?
This DUOL page updates as soon as new STOCK Act disclosures are filed for Duolingo, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
© 2026 - All rights reserved. Powered by Vantara Labs
This website is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office, or her representatives. Any use of her name is solely for the purpose of discussing publicly available information.The information provided on this website is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.